124 related articles for article (PubMed ID: 31463908)
41. Effects of transforming growth factor-beta on aggrecanase production and proteoglycan degradation by human chondrocytes in vitro.
Moulharat N; Lesur C; Thomas M; Rolland-Valognes G; Pastoureau P; Anract P; De Ceuninck F; Sabatini M
Osteoarthritis Cartilage; 2004 Apr; 12(4):296-305. PubMed ID: 15023381
[TBL] [Abstract][Full Text] [Related]
42. Low molecular weight isoforms of the aggrecanases are responsible for the cytokine-induced proteolysis of aggrecan in a porcine chondrocyte culture system.
Powell AJ; Little CB; Hughes CE
Arthritis Rheum; 2007 Sep; 56(9):3010-9. PubMed ID: 17763444
[TBL] [Abstract][Full Text] [Related]
43. Use of anti-neoepitope antibodies for the analysis of degradative events in cartilage and the molecular basis for neoepitope specificity.
Mort JS; Flannery CR; Makkerh J; Krupa JC; Lee ER
Biochem Soc Symp; 2003; (70):107-14. PubMed ID: 14587286
[TBL] [Abstract][Full Text] [Related]
44. Membrane type 1 matrix metalloproteinase (MT1-MMP) cleaves the recombinant aggrecan substrate rAgg1mut at the 'aggrecanase' and the MMP sites. Characterization of MT1-MMP catabolic activities on the interglobular domain of aggrecan.
Büttner FH; Hughes CE; Margerie D; Lichte A; Tschesche H; Caterson B; Bartnik E
Biochem J; 1998 Jul; 333 ( Pt 1)(Pt 1):159-65. PubMed ID: 9639575
[TBL] [Abstract][Full Text] [Related]
45. ADAMTS5-mediated aggrecanolysis in murine epiphyseal chondrocyte cultures.
Stewart MC; Fosang AJ; Bai Y; Osborn B; Plaas A; Sandy JD
Osteoarthritis Cartilage; 2006 Apr; 14(4):392-402. PubMed ID: 16406703
[TBL] [Abstract][Full Text] [Related]
46. Identification of a novel HtrA1-susceptible cleavage site in human aggrecan: evidence for the involvement of HtrA1 in aggrecan proteolysis in vivo.
Chamberland A; Wang E; Jones AR; Collins-Racie LA; LaVallie ER; Huang Y; Liu L; Morris EA; Flannery CR; Yang Z
J Biol Chem; 2009 Oct; 284(40):27352-9. PubMed ID: 19657146
[TBL] [Abstract][Full Text] [Related]
47. Mature bovine articular cartilage contains abundant aggrecan that is C-terminally truncated at Ala719-Ala720, a site which is readily cleaved by m-calpain.
Oshita H; Sandy JD; Suzuki K; Akaike A; Bai Y; Sasaki T; Shimizu K
Biochem J; 2004 Aug; 382(Pt 1):253-9. PubMed ID: 15175011
[TBL] [Abstract][Full Text] [Related]
48. The development and characterization of a competitive ELISA for measuring active ADAMTS-4 in a bovine cartilage ex vivo model.
He Y; Zheng Q; Simonsen O; Petersen KK; Christiansen TG; Karsdal MA; Bay-Jensen AC
Matrix Biol; 2013 Apr; 32(3-4):143-51. PubMed ID: 23295731
[TBL] [Abstract][Full Text] [Related]
49. Intact aggrecan and fragments generated by both aggrecanse and metalloproteinase-like activities are present in the developing and adult rat spinal cord and their relative abundance is altered by injury.
Lemons ML; Sandy JD; Anderson DK; Howland DR
J Neurosci; 2001 Jul; 21(13):4772-81. PubMed ID: 11425904
[TBL] [Abstract][Full Text] [Related]
50. Aggrecanase and metalloproteinase-specific aggrecan neo-epitopes are induced in the articular cartilage of mice with collagen II-induced arthritis.
Singer II; Scott S; Kawka DW; Bayne EK; Weidner JR; Williams HR; Mumford RA; Lark MW; McDonnell J; Christen AJ; Moore VL; Mudgett JS; Visco DM
Osteoarthritis Cartilage; 1997 Nov; 5(6):407-18. PubMed ID: 9536289
[TBL] [Abstract][Full Text] [Related]
51. Aggrecanase and aggrecan degradation in osteoarthritis: a review.
Huang K; Wu LD
J Int Med Res; 2008; 36(6):1149-60. PubMed ID: 19094423
[TBL] [Abstract][Full Text] [Related]
52. Cytokine-induced cartilage proteoglycan degradation is mediated by aggrecanase.
Arner EC; Hughes CE; Decicco CP; Caterson B; Tortorella MD
Osteoarthritis Cartilage; 1998 May; 6(3):214-28. PubMed ID: 9682788
[TBL] [Abstract][Full Text] [Related]
53. Will the real aggrecanase(s) step up: evaluating the criteria that define aggrecanase activity in osteoarthritis.
Tortorella MD; Malfait AM
Curr Pharm Biotechnol; 2008 Feb; 9(1):16-23. PubMed ID: 18289053
[TBL] [Abstract][Full Text] [Related]
54. Matrix metalloproteinases and aggrecanases cleave aggrecan in different zones of normal cartilage but colocalize in the development of osteoarthritic lesions in STR/ort mice.
Chambers MG; Cox L; Chong L; Suri N; Cover P; Bayliss MT; Mason RM
Arthritis Rheum; 2001 Jun; 44(6):1455-65. PubMed ID: 11407708
[TBL] [Abstract][Full Text] [Related]
55. Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5.
Song RH; Tortorella MD; Malfait AM; Alston JT; Yang Z; Arner EC; Griggs DW
Arthritis Rheum; 2007 Feb; 56(2):575-85. PubMed ID: 17265492
[TBL] [Abstract][Full Text] [Related]
56. Removal of O-linked and N-linked oligosaccharides is required for optimum detection of NITEGE neoepitope on ADAMTS4-digested fetal aggrecans: implications for specific N-linked glycan-dependent aggrecanolysis at Glu373-Ala374.
Frank JE; Thompson VP; Brown MP; Sandy JD
Osteoarthritis Cartilage; 2009 Jun; 17(6):777-81. PubMed ID: 19071032
[TBL] [Abstract][Full Text] [Related]
57. Enzymes active in the areas undergoing cartilage resorption during the development of the secondary ossification center in the tibiae of rats ages 0-21 days: I. Two groups of proteinases cleave the core protein of aggrecan.
Lee ER; Lamplugh L; Davoli MA; Beauchemin A; Chan K; Mort JS; Leblond CP
Dev Dyn; 2001 Sep; 222(1):52-70. PubMed ID: 11507769
[TBL] [Abstract][Full Text] [Related]
58. Variations in aggrecan structure modulate its susceptibility to aggrecanases.
Roughley PJ; Barnett J; Zuo F; Mort JS
Biochem J; 2003 Oct; 375(Pt 1):183-9. PubMed ID: 12859252
[TBL] [Abstract][Full Text] [Related]
59. Mannosamine inhibits aggrecanase-mediated changes in the physical properties and biochemical composition of articular cartilage.
Patwari P; Kurz B; Sandy JD; Grodzinsky AJ
Arch Biochem Biophys; 2000 Feb; 374(1):79-85. PubMed ID: 10640399
[TBL] [Abstract][Full Text] [Related]
60. Calpain is involved in C-terminal truncation of human aggrecan.
Struglics A; Hansson M
Biochem J; 2010 Sep; 430(3):531-8. PubMed ID: 20618160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
